Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Autoimmune Illness

Impact of vitamin D receptor activity on experimental autoimmune prostatitis. J Autoimmun. 2009 Mar 6.
Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol. 2009 Mar 3.
Vitamin D metabolism and vitamin D traditional and nontraditional, target organs: implications for kidney patients. J Ren Care. 2009 Mar;35 Suppl 1:39–44.
Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res. 2009 Jan;153(1):11–6.
Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009 Jan;94(1):26–34.
Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep. 2009 Jan;9(1):81–7.
Rheumatic manifestations of renal disease. Curr Opin Rheumatol. 2009 Jan;21(1):55–61.
Induction of tolerogenic dendritic cells by vitamin d receptor agonists. Handb Exp Pharmacol. 2009;(188):251–73. Review.
Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20834–9.
Vitamin D: current status and perspectives. Clin Chem Lab Med. 2008 Dec 22.
The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008 Dec;29(6):369–75. Review.
Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris). 2008 Dec;69(6):501–10. In French.
Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008 Dec;15(6):489–94. Review.
Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities. Mol Aspects Med. 2008 Dec;29(6):376–87.
The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med. 2008 Dec;29(6):369–75.
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity. Mol Aspects Med. 2008 Dec;29(6):433–52.
Adequate level of vitamin D is essential for maintaining good health. Postepy Hig Med Dosw (Online). 2008 Oct 9;62:502–10. In Polish.
Vitamin D and multiple sclerosis. J Cell Biochem. 2008 Oct 1;105(2):338–43.
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726–76. Review.
UV and pigmentation: molecular mechanisms and social controversies. Pigment Cell Melanoma Res. 2008 Oct;21(5):509–16. Review.
Vitamin d signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008 Sep;76(9):3837–43.
The Complex Role of Vitamin D in Autoimmune Diseases. Scand J Immunol. 2008 Sep;68(3):261–9.
Vitamin D and Sunlight: Strategies for Cancer Prevention and Other Health Benefits. Clin J Am Soc Nephrol. 2008 Sep;3(5):1548–54.
Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology (Oxford). 2008 Sep;47(9):1348–51.
Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008 Aug;4(8):404–12.
Vitamin D and anti-aging medicine. Clin Calcium. 2008 Jul;18(7):980–5. Review in Japanese.
The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):408–15. Review.
Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford). 2008 Jun;47(6):840–8.
Vitamin D and living in northern latitudes—an endemic risk area for vitamin D deficiency. Int J Circumpolar Health. 2008 Jun;67(2–3):164–78. Review.
Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population. Int J Immunogenet. 2008 Apr;35(2):125–31.
Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38. Review.
The controversial role of vitamin D in the skin: immunosuppression vs. photoprotection. Clin Exp Dermatol. 2008 Mar;33(2):167–70.
Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol. 2008 Feb;194(1–2):7–17. Review.
Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol. 2008 Feb;69(2):134–8.
A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10. Med Hypotheses. 2008;71(1):85–90.
Therapeutic potential of vitamin D for multiple sclerosis. Curr Med Chem. 2008;15(5):499–505. Review.
Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res. 2007 Dec;22 Suppl 2:V69–73. Review.
Vitamin D insufficiency—possible etiologic factor of autoimmune diseases. Ugeskr Laeger. 2007 Oct 22;169(43):3655–60. Review in Danish.
Modulatory effects of 1,25-dihydroxyvitamin d3 on human B cell differentiation. J Immunol. 2007 Aug 1;179(3):1634–47.
Vitamin D and autoimmune disease. Acta Med Indones. 2007 Jul–Sep;39(3):133–41. Review.
Vitamin d and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 Jun;22(3):297–304. Review.
Vitamin d and its role in cancer and immunity: a prescription for sunlight. Nutr Clin Pract. 2007 Jun;22(3):305–22. Review.
Activation of the human immunodeficiency virus type I long terminal repeat by 1alpha,25-dihydroxyvitamin D3. J Mol Endocrinol. 2007 Jun;38(6):587–601.
Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol). J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):689–93.
Vitamin D and vascular calcification. Curr Opin Lipidol. 2007 Feb;18(1):41–6.
Favourable and unfavourable effects of exposure to sunlight. Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
1,25-Dihydroxyvitamin D(3) regulates genes responsible for detoxification in intestine. Toxicol Appl Pharmacol. 2007 Jan 1;218(1):37–44.
Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007 Jan;62(1):23–8.
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79. Review.
Considering the potential benefits as well as adverse effects of sun exposure: Can all the potential benefits be provided by oral vitamin D supplementation? Prog Biophys Mol Biol. 2006 Sep;92(1):140–9. Review.
Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Review.
1,25 dihydroxyvitamin D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res. 2006 May 15;83(7):1299–309.
Vitamin D and autoimmune disease—implications for practice from the multiple sclerosis literature. J Am Diet Assoc. 2006 Mar;106(3):418–24. Review.
Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis. BJU International Volume 97 Page 617—March 2006.
Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006 Feb;36(2):361–70.
Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):93–101. Review.
D-hormone and the immune system. J Rheumatol Suppl. 2005 Sep;76:11–20.
Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304. Review.
Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol. 2005 Feb;233(2):115–24. Review.
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S–88S. Review.
Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1717S–20S. Review.
Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56. Review.
Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004 Aug;58(8):1095–109. Review.
Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004 May;89–90(1–5):437–41. Review.
Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence. Experimental Biology and Medicine 229:1136–1142 (2004). Review.
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci. 2003 Apr;987:258–61. Review.
The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277–300. Review.
Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology. 2002 Dec 27;181–182:71–8. Review.
Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol. 2002 Jun;2(7):1017–28. Review.
New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002 Apr;13(3):100–5. Review.
The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med. 2002 Apr;8(4):174–9. Review.
Vitamin D: its role and uses in immunology. FASEB J. 2001 Dec;15(14):2579–85. Review.
Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson's disease? Med Hypotheses. 2001 May;56(5):641–5.
Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc. 2000 Nov;59(4):531–5. Review.
1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59 Suppl 1:24–7. Review.
Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence? Experimental Biology and Medicine 223:230–233 (2000). Review.
Disease caused by lack of sunlight: rickets and osteomalacia. Ned Tijdschr Geneeskd. 1999 Mar 20;143(12):593–7. Review in Dutch.
Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab. 1998 Nov;83(11):3832–8.
1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol. 1998 Jun 1;160(11):5314–9.
1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998 Jan;128(1):68–72.
1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions. J Investig Dermatol Symp Proc. 1996 Apr;1(1):68–71. Review.
Immune modulation by vitamin D analogs in the prevention of autoimmune diseases. Verh K Acad Geneeskd Belg. 1995;57(5):371–85; discussion 385–7. In Dutch.
Effects of vitamin D3 and cyclosporin A on HgCl2-induced autoimmunity in Brown Norway rats. Nephrol Dial Transplant (1995) 10: 2020–2026.
1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leuk Res. 1994 Jun;18(6):453–63.
Abnormal vitamin D3 metabolism in patients with primary Sjogren's syndrome. Ann Rheum Dis. 1990 Sep;49(9):682–4.
Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1989 Jul;69(1):127–33.
Effect of 1,25-dihydroxyvitamin D3 on the immunocompetent cells. Methods Find Exp Clin Pharmacol. 1986 Mar;8(3):167–73.

back to research menu

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.